The Robert Schattner Center, University of Pennsylvania, School of Dental Medicine 240 South 40th Street, Philadelphia, PA 19104-6030
Philadelphia –Penn Dental Medicine’s Dr. Henry Daniell has been recognized with a named professorship, becoming the W.D. Miller Professor, effective March 1. This honorific title recognizes his many contributions to Penn Dental Medicine since his recruitment and appointment as Professor in the School’s Department of Biochemistry in 2012. “Dr. Daniell’s work has brought Penn Dental...
A study from the lab of Dr. Kathy Battaglia has characterized a new animal model for age-related macular degeneration that will help to further probe the condition.
Philadelphia – Dr. Henry Daniell, Professor and Interim Chair of the Department of Biochemistry at Penn Dental Medicine, was among the featured panelist at the London Campaign Kickoff Celebration for The Power of Penn: Advancing Knowledge for Good, held November 15 in Plaisterers’ Hall, London. Penn President Amy Gutmann hosted the event that drew Penn...
Philadelphia – Penn Dental Medicine welcomed Pennsylvania State Senators to its high-tech research greenhouse as part of a recent visit by the PA Senate Appropriations Committee members to Pennovation Works, Penn’s hub for innovation, designed to bridge the intellectual and entrepreneurial initiatives for advancing knowledge and generating economic development. The research greenhouse of Dr. Henry...
A project from the lab of Dr. Daniell using his plant-based platform for the production and oral delivery of protein therapies was among those innovations in the capstone course.
Collaborating with Penn Vet, Dr. Kathleen Boesze-Battaglia, Dept. of Biochemistry, contributed her expertise in lipid biochemistry and spectral analysis of lipid debris to the study.
Dr. Hydar Ali, in the Dept. of Pathology, has spent his career discerning mast cells’ unique qualities and honing in on strategies to modulate their activity to improve health.
A new study from the lab of Dr. Henry Daniell gives hope for a therapy to keep hemophilia patients from developing antibodies that cause a rejection of clotting-factor infusions.
Dr. Henry Daniell's lab has designed a software program that converts any given DNA sequence into the sequence preferred by either lettuce or tobacco plants.